A detailed history of Worldquant Millennium Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 7,688 shares of UTHR stock, worth $2.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,688
Previous 42,250 81.8%
Holding current value
$2.76 Million
Previous $13.5 Million 79.54%
% of portfolio
0.02%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $10.8 Million - $12.6 Million
-34,562 Reduced 81.8%
7,688 $2.75 Million
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $3.92 Million - $5.48 Million
-17,176 Reduced 28.9%
42,250 $13.5 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $589,074 - $697,380
-2,795 Reduced 4.49%
59,426 $13.7 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $2.93 Million - $3.5 Million
-13,624 Reduced 17.96%
62,221 $13.7 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $5.33 Million - $6.25 Million
25,186 Added 49.72%
75,845 $17.1 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $2.78 Million - $3.16 Million
13,555 Added 36.53%
50,659 $11.2 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $7.9 Million - $10.2 Million
37,104 New
37,104 $8.31 Million
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $326,905 - $519,241
-4,298 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$107.15 - $126.84 $21,430 - $25,368
200 Added 4.88%
4,298 $504,000
Q4 2018

Feb 14, 2019

BUY
$101.4 - $128.73 $80,613 - $102,340
795 Added 24.07%
4,098 $446,000
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $27,200 - $30,940
239 Added 7.8%
3,303 $422,000
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $309,892 - $362,501
3,064 New
3,064 $347,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.